AVPN Global Conference 2026: ITB Rector Promotes Convergence of Knowledge for Health Innovation
- Posted: September 16, 2026
- By: stg-bpudl
- Category: Uncategorized
New Delhi, August 25, 2026. Rector of Institut Teknologi Bandung (ITB), Prof. Dr. Ir. Tatacipta Dirgantara, M.T., was one of the speakers at the AVPN Global Conference 2026, an annual forum organized by the Asian Venture Philanthropy Network (AVPN). The forum brings together social investors, philanthropists, business leaders, policymakers, and other stakeholders working in development and social impact across Asia.
The conference, themed “A Blueprint for Action in Asia,” was held from August 25–27, 2026, at Bharat Mandapam, New Delhi, India. ITB’s participation in the forum provided an opportunity to expand its international network, build strategic partnerships, and explore new funding opportunities for innovation and sustainable development programs.

Prof. Tatacipta spoke at a session titled “The Next Frontier in Global Health: Convergence, Prevention, and Innovation.” The session discussed a major challenge in the future of health development: how to create innovations that are not only scientifically strong, but also provide real, affordable, and sustainable benefits to society.
In the session, Prof. Tatacipta joined a discussion with several leaders from different sectors, including Chetna Gala Sinha, Founder and Chair of Mann Deshi Bank & Mann Deshi Foundation, India; Jesper Moller, Deputy Representative for Programmes at UNICEF India; and Usha Viswanathen, Head of Health and Well-being at Temasek Foundation. The discussion was moderated by Prof. Sankalp Chaturvedi, Co-Director of the Gandhi Centre for Inclusive Innovation and Associate Dean for People and Culture at Imperial College Business School.

Prof. Tatacipta explained that the main challenge in health development in Indonesia is not a lack of ideas or innovations. Instead, the challenge is how to bring proven solutions to a wider population and ensure that they can be implemented sustainably.
He highlighted several ITB innovations that have created real impact. These include the Merah Putih Vaccine, which was developed together with a consortium of six institutions during the pandemic; Vent-I, a ventilator that has been used in around 1,000 hospitals and healthcare facilities; and NIVA and heartGO, technologies that can help detect cardiovascular risks at an early stage without requiring patients to visit a hospital.
He also highlighted an affordable prosthetic leg developed by ITB. The prosthetic leg was specifically designed to allow users to pray while sitting cross-legged, providing a solution for accident survivors who have undergone amputation. According to Prof. Tatacipta, although the product was developed using a commercial approach to reduce production costs, it provides significant social benefits for its users.
He also discussed the health challenges and basic needs that Indonesia continues to face, including malnutrition and stunting. According to him, one of the key strengths of universities is their ability to bring together different fields of knowledge, including digital technology, artificial intelligence, data analytics, biosciences, pharmaceuticals, and engineering, as well as social sciences, economics, and business, to develop more comprehensive health solutions.
Prof. Tatacipta emphasized that the success of university innovation should not be measured only by the number of publications or the level of technological sophistication. Instead, it should be measured by how effectively knowledge can be transformed into real solutions that have an impact on society.
He added that achieving this requires an ecosystem that brings together universities, governments, businesses, investors, philanthropic organizations, healthcare professionals, and communities. This collaboration is needed throughout the entire process, from technology development and funding to implementation and scaling up innovations.
ITB’s participation in the AVPN Global Conference 2026 further strengthens the strategic role of universities as a bridge between knowledge, innovation, and impact. Through the convergence of knowledge and cross-border collaboration, ITB has the opportunity to strengthen its contribution to developing world-class health innovations that remain relevant and beneficial to Indonesia and Asia.